Chiniara Ellen Insider Trades

Insider Trading History

Track insider trading activity for Chiniara Ellen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $189k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 90,000 shares
$5.17
$2.10
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Legal Officer
Holding Value $6.03M 82,326 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 55,000 shares
$30.17
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Legal Officer
Holding Value $5.89M 80,493 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$68.2k 2,241 shares
$30.45
$73.21
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $84k 40,000 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146k 40,000 shares
$3.65
$2.10
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Legal Officer
Holding Value $4.01M 54,826 shares
Last Trade
Jan 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$131k 3,129 shares
$41.75
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Legal Officer
Holding Value $9.56M 130,531 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.68M 130,531 shares
$43.50
$73.21
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $84k 40,000 shares
Last Trade
Feb 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.8k 40,000 shares
$1.57
$2.10
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Legal Officer
Holding Value $2.5M 34,205 shares
Last Trade
Jan 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$89.7k 3,295 shares
$27.22
$73.21
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $84k 40,000 shares
Last Trade
Feb 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$157k 40,000 shares
$3.93
$2.10
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Legal Officer
Holding Value $16.5M 225,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.52M 262,500 shares
$24.84
$73.21
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $94.5k 45,000 shares
Last Trade
Apr 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68k 45,000 shares
$1.51
$2.10
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Jul 21, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21.3M 116,850 shares
$182.50
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $11.4M 62,381 shares
Last Trade
Feb 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.95M 19,321 shares
$152.75
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $11.5M 62,917 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6M 37,965 shares
$158.03
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $7.85M 43,004 shares
Last Trade
Dec 16, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.15M 19,913 shares
$157.96
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $7.86M 43,060 shares
Last Trade
Dec 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.84k 56 shares
$157.91
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $4.54M 24,898 shares
Last Trade
Mar 02, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$114k 1,263 shares
$90.54
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $4.77M 26,161 shares
Last Trade
Feb 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$959k 10,200 shares
$94.03
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & Chief Legal Officer
Holding Value $4.55M 24,952 shares
Last Trade
Dec 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.96k 54 shares
$110.42
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & General Counsel
Holding Value $2.91M 15,961 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 8,250 shares
$135.33
$182.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up